Chow G

Title : Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII alpha1 Chain - Logan_2015_Am.J.Hum.Genet_97_878

Author(s) : Logan CV , Cossins J , Rodriguez Cruz PM , Parry DA , Maxwell S , Martinez-Martinez P , Riepsaame J , Abdelhamed ZA , Lake AV , Moran M , Robb S , Chow G , Sewry C , Hopkins PM , Sheridan E , Jayawant S , Palace J , Johnson CA , Beeson D

Ref : American Journal of Human Genetics , 97 :878 , 2015

Abstract : Logan_2015_Am.J.Hum.Genet_97_878

ESTHER : Logan_2015_Am.J.Hum.Genet_97_878

PubMedSearch : Logan_2015_Am.J.Hum.Genet_97_878

PubMedID: 26626625

Title : Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study - Mega_2005_Arch.Neurol_62_721

Author(s) : Mega MS , Dinov ID , Porter V , Chow G , Reback E , Davoodi P , O'Connor SM , Carter MF , Amezcua H , Cummings JL

Ref : Archives of Neurology , 62 :721 , 2005

Abstract : Mega_2005_Arch.Neurol_62_721

ESTHER : Mega_2005_Arch.Neurol_62_721

PubMedSearch : Mega_2005_Arch.Neurol_62_721

PubMedID: 15883258

Chow G

References (2)

1. Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII alpha1 Chain

2. Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study